Six people tests coronavirus positive in Maha FDA
A majority of them contracted the virus during field visits
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Govt may allow 30 per cent import of chemicals/intermediates in PLI scheme
In the next phase of the PLI scheme, the government has plans to incentivise excipient manufacturers
Serum to apply for local trials on Oxford’s vaccine in a week: CEO
SII, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the…
FabiFlu more affordable than other drugs: Glenmark to DCGI
The company also sends its justifications and clarifications to allegations of false claims about FabiFlu’s use for COVID-19…
Biocon Biologics and Voluntis collaborate on digital therapeutics for insulins
Insulia is the first digital therapeutic with regulatory clearance to provide automated titration recommendations for all types of…
Over 158 applications for generic products pending with US FDA for approval: Lupin
Sharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business…
DCGI nod for Jubilant’s generic remdesivir under brand name JUBI-R
The company will distribute the drug in the Indian market through its distribution network and will be available by the first week…
China’s indigenously developed COVID-19 vaccines set to surprise the world: GlobalData
China's Sinopharm and Sinovac (in collaboration with Brazil-based Butantan) have both reported encouraging results in the early…
Draw up immunisation strategy now itself for COVID-19 vaccine: Kiran Mazumdar-Shaw
"If the Bharat Biotech vaccine, or Zydus Cadila vaccine starts showing good, promising results, we could also have it (vaccine) by…
Oxford University coronavirus vaccine induces immune response: Lancet
The findings are seen as promising, but experts feel it is too soon to know if this is enough to offer protection as larger trials…
Remdesivir treatment gains popularity in India, black marketing and price cuts to continue:…
According to figures compiled by the CDSCO, India will be producing 20,000 vials per day by the end of July.
Hand sanitisers under Schedule K: Pharma Inc happy, regulators cite concerns
Schedule-K will allow hand sanitisers to be sold without a sale license
Mylan commences supply of remdesivir in India under brand name DESREM
The company also launched a 24/7 helpline number to give out information about the availability of the drug
Cipla, Amgen settle case involving generic cinacalcet hydrochloride tablets
Cipla's cinacalcet hydrochloride tablets, in the strengths of 30mg, 60mg and 90mg, are generic versions of Sensipar, a branded…
DCGI queries pharma company on its claim of FabiFlu use for COVID-19 patients with comorbidities
As per statement by the Glenmark and media reports, the DCGI had accelerated the process for clinical trials and reviews…
Russia to mass produce experimental COVID-19 vaccine – wealth fund head
A larger Phase III trial involving several thousand people is expected to begin in August, said Russian Direct Investment Fund…
Alembic Pharmaceuticals receives US FDA’s tentative approval for Empagliflozin and Metformin…
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Synjardy Tablets of…
Seven Indian pharmaceutical companies race to develop vaccine for deadly coronavirus
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the…
Dexamethasone’s COVID-19 benefits confirmed; spotlight on immune cells
The full results of a large randomized clinical trial in Britain looking at the steroid dexamethasone confirmed the benefits in…
Indiscriminate use led to bogus tocilizumab injections: FDCA
A racket selling spurious tocilizumab injections which are used in the treatment of COVID-19 was recently busted following raids…